Ryan Filiatreau, PA
Physician Assistant · Richmond, KYNPI 1922296664
Payments from drug & device makers
Across 88 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$294
- Novartis$213
- E.r. Squibb & Sons, L.L.C.$180
- Lilly USA, LLC$131
- Amgen$120
- Sun Pharmaceutical Industries Inc.$117
- plus $539 from 11 others
What the payments were for
- Food & beverage$1,41689%
- Education$17911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $294 |
| Novartis | 12 | $213 |
| E.r. Squibb & Sons, L.L.C. | 7 | $180 |
| Lilly USA, LLC | 8 | $131 |
| Amgen | 8 | $120 |
| Sun Pharmaceutical Industries Inc. | 7 | $117 |
| AbbVie | 5 | $103 |
| LEO Pharma Inc. | 6 | $102 |
| UCB, Inc. | 6 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Almirall LLC | 4 | $54 |
| Pfizer | 3 | $45 |
| Sanofi | 2 | $34 |
| Boehringer Ingelheim | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Incyte Corporation | 1 | $13 |
How this compares
$1,595 in reported general payments places this provider in the 75th percentile of 1,448 physician assistant providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 15 | $308,495 |
| Humira(Cf) PenAdalimumab | 34 | $267,489 |
| Dupixent PenDupilumab | 68 | $261,424 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 31 | $247,097 |
| Cosentyx Unoready PenSecukinumab | 24 | $168,669 |
| Taltz AutoinjectorIxekizumab | 12 | $81,329 |
| Dupixent SyringeDupilumab | 18 | $70,515 |
| Clobetasol Propionate | 105 | $3,880 |
| Fluocinonide | 80 | $3,362 |
| Ketoconazole | 246 | $3,171 |
| Metronidazole | 61 | $2,940 |
| Doxycycline Hyclate | 132 | $2,646 |
| Fluorouracil | 28 | $2,422 |
| Triamcinolone Acetonide | 157 | $1,922 |
| Tacrolimus | 16 | $1,187 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Richmond
- Brandice HarrisonLexington$745K
- Lauren MeadeLexington$656K
- Melissa DavisLouisville$362K
- Kara MuddLouisville$98K
- Seth KingBowling Green$91K
- Marty MullinsHazard$63K
- Lauri GarnerVersailles$33K
- Robert TatumLouisville$29K
- Michelle JonesLexington$29K
- Grace IsaacsLouisville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.